|
|||||
|
|
miR-30b-5p inhibits cancer progression and enhances cisplatin sensitivity in lung cancer through targeting LRP8 |
|
| Authors: | Qiu Haitao Shen Xiaokang Chen Bing Chen Tianming Feng Guodong Chen Shilin Feng Dongjie Xu Qiaoshu |
| Affiliation: | 1.Department of Thoracic Surgery, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Collaborative Innovation Center for Cancer Personalized Medicine, No. 42, Baiziting, Xuanwu district, Nanjing, 210009, China ;2.The Fourth Clinical College of Nanjing Medical University, Nanjing, 210009, China ;3.Nanjing Medical University, Third Affiliated Hospital, Nanjing, 210009, China ;4.Department of Interventional Therapy, The Affiliated Cancer Hospital of Nanjing Medical University & Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing, 210009, China ;5.State Key Laboratory of Bioelectronics, Jiangsu Key Laboratory of Biomaterials and Devices, School of Biological Science and Medical Engineering, Southeast University, Nanjing, 210009, China ; |
| Abstract: | Apoptosis - Accumulated evidence has demonstrated that miRNAs are closely implicated in lung carcinogenesis. Herein, we explored the expression pattern of miR-30b-5p in lung cancer, and aimed to... |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |